Target-matched therapies in patients with advanced cervical cancers harboring PIK3CA mutations and/or PTEN loss.

被引：0
|
作者：
Hou, Ming-Mo [1 ]
Liu, Xiaochun [1 ]
Piha-Paul, Sarina A. [1 ]
Janku, Filip [1 ]
Wheler, Jennifer [1 ]
Naing, Aung [1 ]
Bodurka, Diane [1 ]
Schmeler, Kathleen [1 ]
Lu, Karen [1 ]
Zinner, Ralph [1 ]
Hong, David [1 ]
Meric-Bernstam, Funda [1 ]
Kurzrock, Razelle [2 ]
Fu, Siqing [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] UC San Diego Moores Canc Ctr, La Jolla, CA USA
来源：
MOLECULAR CANCER THERAPEUTICS | 2013年 / 12卷 / 11期
关键词：
D O I：
10.1158/1535-7163.TARG-13-B191
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B191
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Evaluation of the association of PIK3CA mutations and PTEN loss with efficacy of trastuzumab therapy in metastatic breast cancer
    E. Razis
    M. Bobos
    V. Kotoula
    A. G. Eleftheraki
    H. P. Kalofonos
    K. Pavlakis
    P. Papakostas
    G. Aravantinos
    G. Rigakos
    I. Efstratiou
    K. Petraki
    D. Bafaloukos
    I. Kostopoulos
    D. Pectasides
    K. T. Kalogeras
    D. Skarlos
    G. Fountzilas
    Breast Cancer Research and Treatment, 2011, 128 : 447 - 456
  • [32] The role of PIK3CA mutations as a predictor of outcomes and a therapeutic target
    Wang G.M.
    Park B.H.
    Current Breast Cancer Reports, 2010, 2 (4) : 167 - 173
  • [33] Evaluation of the association of PIK3CA mutations and PTEN loss with efficacy of trastuzumab therapy in metastatic breast cancer
    Razis, E.
    Bobos, M.
    Kotoula, V.
    Eleftheraki, A. G.
    Kalofonos, H. P.
    Pavlakis, K.
    Papakostas, P.
    Aravantinos, G.
    Rigakos, G.
    Efstratiou, I.
    Petraki, K.
    Bafaloukos, D.
    Kostopoulos, I.
    Pectasides, D.
    Kalogeras, K. T.
    Skarlos, D.
    Fountzilas, G.
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 128 (02) : 447 - 456
  • [34] PIK3CA mutations and PTEN loss correlate with similar prognostic factors and are not mutually exclusive in breast cancer
    Perez-Tenorio, Gizeh
    Alkhori, Liza
    Olsson, Birgit
    Waltersson, Marie Ahnstrom
    Nordenskjold, Bo
    Rutqvist, Lars Erik
    Skoog, Lambert
    Stal, Olle
    CLINICAL CANCER RESEARCH, 2007, 13 (12) : 3577 - 3584
  • [35] PIK3CA mutations are mutually exclusive with PTEN loss in diffuse large B-cell lymphoma
    J Abubaker
    P P Bavi
    S Al-Harbi
    A K Siraj
    F Al-Dayel
    S Uddin
    K Al-Kuraya
    Leukemia, 2007, 21 : 2368 - 2370
  • [36] PIK3CA mutations are mutually exclusive with PTEN loss in diffuse large B-cell lymphoma
    Abubaker, J.
    Bavi, P. P.
    Al-Harbi, S.
    Siraj, A. K.
    Al-Dayel, F.
    Uddin, S.
    Al-Kuraya, K.
    LEUKEMIA, 2007, 21 (11) : 2368 - 2370
  • [37] Clinicopathologic analysis of breast cancers with PIK3CA mutations in Japanese women
    Maruyama, Naomi
    Miyoshi, Yasuo
    Taguchi, Tetsuya
    Tamaki, Yasuhiro
    Monden, Morito
    Noguchi, Shinzaburo
    CLINICAL CANCER RESEARCH, 2007, 13 (02) : 408 - 414
  • [38] Oncogenic PIK3CA mutations reprogram glutamine metabolism in colorectal cancers
    Wang, Zhenghe
    MOLECULAR CANCER RESEARCH, 2016, 14
  • [39] PIK3CA and PTEN mutations in adenoid cystic carcinoma of the breast metastatic to kidney
    Vranic, Semir
    Bilalovic, Nurija
    Lee, Lisa M. J.
    Kruslin, Bozo
    Litleberg, Stan L.
    Gatatica, Zoran
    HUMAN PATHOLOGY, 2007, 38 (09) : 1425 - 1431
  • [40] PIK3CA mutations and copy number gains in human lung cancers
    Yamamoto, Hiromasa
    Shigematsu, Hisayuki
    Nomura, Masaharu
    Lockwood, William W.
    Sato, Mitsuo
    Okumura, Naoki
    Soh, Junichi
    Suzuki, Makoto
    Wistuba, Ignacio I.
    Fong, Kwun M.
    Lee, Huei
    Toyooka, Shinichi
    Date, Hiroshi
    Lam, Wan L.
    Minna, John D.
    Gazdar, Adi F.
    CANCER RESEARCH, 2008, 68 (17) : 6913 - 6921
12345